Profile of blonanserin for the treatment of schizophrenia

Tomomi Tenjin, Seiya Miyamoto, Yuriko Ninomiya, Rei Kitajima, Shin Ogino, Nobumi Miyake, Noboru YamaguchiDepartment of Neuropsychiatry, St Marianna University School of Medicine, Kawasaki, Kanagawa, JapanAbstract: Blonanserin was developed as an antipsychotic drug in Japan and approved for the treat...

Full description

Bibliographic Details
Main Authors:	Tenjin T, Miyamoto S, Ninomiya Y, Kitajima R, Ogino S, Miyake N, Yamaguchi N
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-04-01
Series:	Neuropsychiatric Disease and Treatment
Online Access:	http://www.dovepress.com/profile-of-blonanserin-for-the-treatment-of-schizophrenia-a12902

Similar Items

Early prediction of blonanserin response in Japanese patients with schizophrenia
by: Kishi T, et al.
Published: (2014-09-01)

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi T, et al.
Published: (2016-11-01)

Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases
by: Hashimoto Kenji, et al.
Published: (2010-04-01)

Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
by: Mitsukuni Murasaki, et al.
Published: (2021-09-01)

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
by: Hori H, et al.
Published: (2014-03-01)

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
by: Imamura, A., et al.
Published: (2021)

Safety and effectiveness of oral blonanserin for schizophrenia: A review of Japanese post-marketing surveillances
by: Yoshifumi Inoue, et al.
Published: (2021-01-01)

Blonanserin overdose: A case report
by: Sandeep Kumar Goyal, et al.
Published: (2019-01-01)

Blonanserin suppresses impulsive action in rats
by: Naoya Nishitani, et al.
Published: (2019-11-01)

Simple and Sensitive Analysis of Blonanserin and Blonanserin C in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry and Its Application
by: Yunliang Zheng, et al.
Published: (2014-01-01)

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
by: Okazaki K, et al.
Published: (2016-12-01)

Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
by: Taro Kishi, et al.
Published: (2014-01-01)

Comparison of long-term efficacy and safety of blonanserin treatment in individuals with first-episode and relapsed schizophrenia: a 3-year retrospective study
by: Lyang Huh, et al.
Published: (2019-10-01)

Blonanserin – A Novel Antianxiety and Antidepressant Drug? An Experimental Study
by: Ramchandra Prabhakar Limaye, et al.
Published: (2016-09-01)

Clinical Assessment of Weight Gain with Atypical Antipsychotics - Blonanserin vs Amisulpride
by: TS DEEPAK, et al.
Published: (2015-06-01)

Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial
by: Bo, Q., et al.
Published: (2022)

Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range
by: Satoko Baba, et al.
Published: (2015-03-01)

Profile of minocycline and its potential in the treatment of schizophrenia
by: Zhang L, et al.
Published: (2014-06-01)

Autistic traits and cognitive profiles of treatment-resistant schizophrenia
by: Yusuke Nakata, et al.
Published: (2020-12-01)

Diagnosis and Treatment of Depression in Patients with Schizophrenia
by: Sergey N. Mosolov
Published: (2020-12-01)

Metabolic profiling of patients with schizophrenia.
by: Rima Kaddurah-Daouk
Published: (2006-08-01)

Psychomotor Profile of People with Schizophrenia
by: Shu-Mei Wang, et al.
Published: (2007)

Role of aripiprazole in treatment-resistant schizophrenia
by: Mossaheb N, et al.
Published: (2012-05-01)

Genome-Wide Methylation Profiling of Schizophrenia
by: Rukova B., et al.
Published: (2014-12-01)

Comparison of demographic profile of patient with schizophrenia and depression
by: Sateesh R Koujalgi, et al.
Published: (2013-01-01)

Effect of isopropyl myristate on the viscoelasticity and drug release of a drug-in-adhesive transdermal patch containing blonanserinEffect of isopropyl myristate on the viscoelasticity and drug release of a drug-in-adhesive transdermal patch containing blonanserinretain-->
by: Chunyi Zhao, et al.
Published: (2016-10-01)

Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
by: Rosaria Di Lorenzo, et al.
Published: (2010-09-01)

Methylomic and transcriptomic profiling of the schizophrenia brain
by: Viana, Joana Fortio Fernandes Pacheco
Published: (2016)

The Group of Treatment Resistant Schizophrenias. Heterogeneity in Treatment Resistant Schizophrenia (TRS)
by: Bruce J. Kinon
Published: (2019-01-01)

Comparison of the demographic profile among caregivers of schizophrenia and depression
by: Sateesh R Koujalgi, et al.
Published: (2013-01-01)

Schizophrenia Treatment The New Facets
Published: (2016)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
by: Jeffrey R Bishop, et al.
Published: (2008-03-01)

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia
by: Chen L, et al.
Published: (2013-06-01)

Electronarcosis in the treatment of schizophrenia
by: Monro, A. B.
Published: (1949)

Monitoring of clozapine and norclozapine concentrations in schizophrenia treatment
by: N. V. Baymeeva, et al.
Published: (2018-02-01)

Behavioral Phenotypes for Negative Symptoms in Animal Models of Schizophrenia
by: Yoshiaki Miyamoto, et al.
Published: (2014-04-01)

Distinct Episodic Verbal Memory Profiles in Schizophrenia
by: Sonia Dollfus, et al.
Published: (2013-04-01)

Comparison of peripheral and central schizophrenia biomarker profiles.
by: Laura W Harris, et al.
Published: (2012-01-01)

The schizophrenia oral health profile: Development and feasibility
by: Frederic Denis, et al.
Published: (2018-09-01)

The first decade and beyond of transcriptional profiling in schizophrenia
by: P. Adolfo Sequeira, et al.
Published: (2012-01-01)